Bioqual, Inc. (BIOQ)
OTCMKTS · Delayed Price · Currency is USD
33.00
0.00 (0.00%)
At close: Aug 31, 2026

Bioqual Statistics

Total Valuation

Bioqual has a market cap or net worth of 29.52 million. The enterprise value is 49.70 million.

Market Cap29.52M
Enterprise Value 49.70M

Important Dates

The next estimated earnings date is Friday, October 16, 2026.

Earnings Date Oct 16, 2026
Ex-Dividend Date n/a

Share Statistics

Bioqual has 894,416 shares outstanding.

Current Share Class 894,416
Shares Outstanding 894,416
Shares Change (YoY) n/a
Shares Change (QoQ) n/a
Owned by Insiders (%) 39.76%
Owned by Institutions (%) n/a
Float 205,671

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 0.74
PB Ratio 0.84
P/TBV Ratio 0.87
P/FCF Ratio 4.97
P/OCF Ratio 4.70
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 1.24
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF 8.37

Financial Position

Current Ratio n/a
Quick Ratio n/a
Debt / Equity 0.96
Debt / EBITDA n/a
Debt / FCF 5.64
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -11.71% and return on invested capital (ROIC) is -6.73%.

Return on Equity (ROE) -11.71%
Return on Assets (ROA) n/a
Return on Invested Capital (ROIC) -6.73%
Return on Capital Employed (ROCE) n/a
Weighted Average Cost of Capital (WACC) 1.75%
Revenue Per Employee 353,517
Profits Per Employee -36,890
Employee Count 113
Asset Turnover n/a
Inventory Turnover n/a

Taxes

In the past 12 months, Bioqual has paid 452,495 in taxes.

Income Tax 452,495
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -23.59% in the last 52 weeks. The beta is -0.09, so Bioqual's price volatility has been lower than the market average.

Beta (5Y) -0.09
52-Week Price Change -23.59%
50-Day Moving Average 52.95
200-Day Moving Average 73.02
Relative Strength Index (RSI) 19.02
Average Volume (20 Days) 654

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) 0.03

Income Statement

In the last 12 months, Bioqual had revenue of 39.95 million and -4.17 million in losses. Loss per share was -4.66.

Revenue39.95M
Gross Profit -3.72M
Operating Income -3.72M
Pretax Income -3.72M
Net Income -4.17M
EBITDA -1.47M
EBIT -3.72M
Loss Per Share -4.66
Full Income Statement

Balance Sheet

The company has 13.29 million in cash and 33.48 million in debt, with a net cash position of -20.18 million or -22.57 per share.

Cash & Cash Equivalents 13.29M
Total Debt 33.48M
Net Cash -20.18M
Net Cash Per Share -22.57
Equity (Book Value) 35.02M
Book Value Per Share 39.15
Working Capital n/a
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 6.28 million and capital expenditures -346,166, giving a free cash flow of 5.94 million.

Operating Cash Flow 6.28M
Capital Expenditures -346,166
Depreciation & Amortization 2.24M
Net Borrowing n/a
Free Cash Flow 5.94M
FCF Per Share 6.64
Full Cash Flow Statement

Margins

Gross margin is -9.30%, with operating and profit margins of -9.30% and -10.44%.

Gross Margin -9.30%
Operating Margin -9.30%
Pretax Margin -9.30%
Profit Margin -10.44%
EBITDA Margin -3.69%
EBIT Margin -9.30%
FCF Margin 14.02%

Dividends & Yields

This stock pays an annual dividend of 0.50, which amounts to a dividend yield of 1.52%.

Dividend Per Share 0.50
Dividend Yield 1.52%
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
FCF Payout Ratio n/a
Buyback Yield n/a
Shareholder Yield 1.52%
Earnings Yield -14.12%
FCF Yield 20.12%
Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

The last stock split was on October 28, 1997. It was a reverse split with a ratio of 0.16666.

Last Split Date Oct 28, 1997
Split Type Reverse
Split Ratio 0.16666

Scores

Altman Z-Score n/a
Piotroski F-Score 2